Experiment set3IT001 for Sinorhizobium meliloti 1021

Compare to:

L-Arginine nitrogen source

Group: nitrogen source
Media: RCH2_defined_Glucose_noNitrogen + L-Arginine (20 mM), pH=7
Culturing: Smeli_ML6, 24 deep-well microplate; Multitron, Aerobic, at 30 (C), shaken=750 rpm
Growth: about 6.2 generations
By: Mark on 3/3/2016
Media components: 0.1 g/L Potassium Chloride, 0.6 g/L Sodium phosphate monobasic monohydrate, 20 mM D-Glucose, 30 mM PIPES sesquisodium salt, Wolfe's mineral mix (0.03 g/L Magnesium Sulfate Heptahydrate, 0.015 g/L Nitrilotriacetic acid, 0.01 g/L Sodium Chloride, 0.005 g/L Manganese (II) sulfate monohydrate, 0.001 g/L Cobalt chloride hexahydrate, 0.001 g/L Zinc sulfate heptahydrate, 0.001 g/L Calcium chloride dihydrate, 0.001 g/L Iron (II) sulfate heptahydrate, 0.00025 g/L Nickel (II) chloride hexahydrate, 0.0002 g/L Aluminum potassium sulfate dodecahydrate, 0.0001 g/L Copper (II) sulfate pentahydrate, 0.0001 g/L Boric Acid, 0.0001 g/L Sodium Molybdate Dihydrate, 0.003 mg/L Sodium selenite pentahydrate), Wolfe's vitamin mix (0.1 mg/L Pyridoxine HCl, 0.05 mg/L 4-Aminobenzoic acid, 0.05 mg/L Lipoic acid, 0.05 mg/L Nicotinic Acid, 0.05 mg/L Riboflavin, 0.05 mg/L Thiamine HCl, 0.05 mg/L calcium pantothenate, 0.02 mg/L biotin, 0.02 mg/L Folic Acid, 0.001 mg/L Cyanocobalamin)
Growth plate: Nplate1 A1

Specific Phenotypes

For 6 genes in this experiment

For nitrogen source L-Arginine in Sinorhizobium meliloti 1021

For nitrogen source L-Arginine across organisms

SEED Subsystems

Subsystem #Specific
Lacto-N-Biose I and Galacto-N-Biose Metabolic Pathway 1
Lactose and Galactose Uptake and Utilization 1
N-linked Glycosylation in Bacteria 1
Rhamnose containing glycans 1
linker unit-arabinogalactan synthesis 1

Metabolic Maps

Color code by fitness: see overview map or list of maps.

Maps containing gene(s) with specific phenotypes:

MetaCyc Pathways

Pathways that contain genes with specific phenotypes:

Pathway #Steps #Present #Specific
sulfoquinovosyl diacylglycerol biosynthesis 2 2 2
UDP-α-D-galactose biosynthesis 1 1 1
UDP-N-acetyl-D-galactosamine biosynthesis I 1 1 1
glycogen biosynthesis II (from UDP-D-Glucose) 4 3 2
UDP-α-D-galactofuranose biosynthesis 2 1 1
D-galactose detoxification 3 1 1
D-galactose degradation I (Leloir pathway) 5 3 1
lipid IVA biosynthesis (E. coli) 6 6 1
lipid IVA biosynthesis (H. pylori) 6 6 1
lipid IVA biosynthesis (generic) 6 6 1
lipid IVA biosynthesis (2,3-diamino-2,3-dideoxy-D-glucopyranose-containing) 6 6 1
lipid IVA biosynthesis (Vibrio cholerae serogroup O1 El Tor) 6 6 1
lipid IVA biosynthesis (P. putida) 6 6 1
superpathway of UDP-glucose-derived O-antigen building blocks biosynthesis 6 4 1
UDP-N-acetyl-D-galactosamine biosynthesis II 7 5 1
stachyose degradation 7 4 1
lipid IVA biosynthesis (P. gingivalis) 9 9 1
UDP-sugars interconversion 9 4 1
teichuronic acid biosynthesis (B. subtilis 168) 9 2 1
colanic acid building blocks biosynthesis 11 6 1
superpathway of (Kdo)2-lipid A biosynthesis 17 11 1
mycolyl-arabinogalactan-peptidoglycan complex biosynthesis 18 1 1
superpathway of Kdo2-lipid A biosynthesis 25 11 1
superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis 33 12 1